Why Yirdoc?
● Self-developed Nebulizer Mesh Membrane :
SUS316 medical grade alloy material, high-precision laser drilling, independently developed ultra-clean cleaning process, no residue falling off; the spray film has been validated for biological and pharmaceutical safety and has no side effects.
● Rate（≥0.2ml/min), TDD（6549.21 ± 131.08μg), High pulmonary deposition rate.
● Using the aerosol canister can reduce the dispersion of drug aerosols and enhance the pulmonary deposition of medications.
● Spiral intake one-way valve patented technology that improves delivery total volume.
● Low residual drug volume: The design of a tapered and angled nebulizer cup facilitates thorough atomization of medication solution.
● Nebulizer & Data Monitoring Software Customization.
● Core Technology: Nebulizing results optimization.
● One Stop Solution: Full development lifecycle support:
Preclinical Trial --- Formulation nebulization feasibility analysis；Drug-device combination feasibility analysis.
Clinical Trial --- Nebulizer customization and development; Patient adherence assessment software customization.
Commercialization --- Specialized device nebulizer production; Intellectual property & registration certification service.
● Yirdoc has own R&D center and manufacturing plant, strictly controls product quality, with low R&D and production costs, and more competitive prices.
